Clinical Trial Update: The Use of Propranolol to Block Memory Reconsolidation in PTSD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating propranolol to block memory reconsolidation in posttraumatic stress disorder has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Wayne State University | Conditions: Posttraumatic Stress Disorders | Phase 2 | Status: TERMINATED